 |
|
nilutamide
A synthetic, nonsteroidal agent with antiandrogenic properties. Nilutamide preferentially binds to androgen receptors and blocks androgen receptor activation by testosterone and other androgens; this agent may inhibit androgen-dependent growth of normal and neoplastic prostate cells. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| US brand name: | | Nilandron | | | | Foreign brand name: | | Anandron | | | | Abbreviation: | | ANAN | | | | Code name: | | RU-23908 | | | | Chemical structure names: | | - 1-(3'-Trifluoromethyl-4'-nitrophenyl)-4,4-dimethylimidazoline-3,5-dione
- 5,5-Dimethyl-3-[4-nitro-3-(trifluoro-methyl)phenyl]-2,4-imidazolidinedione
| | |
|
|
